HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan L Kaufman Selected Research

filanesib

1/2022Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
12/2017A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.
11/2016A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan L Kaufman Research Topics

Disease

62Multiple Myeloma
06/2022 - 04/2006
7Neoplasms (Cancer)
10/2022 - 01/2006
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 04/2012
5Peripheral Nervous System Diseases (PNS Diseases)
11/2015 - 06/2012
5Lymphoma (Lymphomas)
06/2014 - 04/2006
4Disease Progression
01/2022 - 06/2012
4Hematologic Neoplasms (Hematological Malignancy)
06/2014 - 08/2011
3Infections
02/2022 - 01/2012
3Thrombocytopenia (Thrombopenia)
01/2016 - 10/2014
3Fatigue
01/2016 - 08/2010
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 07/2012
2Smoldering Multiple Myeloma
10/2020 - 12/2018
2Immunoglobulin Light-chain Amyloidosis
01/2020 - 01/2018
2Chromosome Aberrations (Chromosome Abnormalities)
12/2019 - 01/2017
2Anemia
11/2018 - 01/2016
2Neutropenia
01/2017 - 12/2014
2Injection Site Reaction
09/2013 - 06/2009
2Virus Diseases (Viral Diseases)
01/2012 - 02/2004
2Renal Insufficiency (Renal Failure)
02/2008 - 03/2007
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2021
1Amyloid Plaque
01/2018
1Myocarditis (Carditis)
01/2018
1Plasma Cell Leukemia
01/2017
1Chronic Kidney Failure (Chronic Renal Failure)
03/2016
1Nausea
01/2016
1Diarrhea
01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2015
1Skin Diseases (Skin Disease)
12/2014
1Lymphopenia (Lymphocytopenia)
10/2014
1Asthenia
10/2014
1Mucositis
06/2014
1Stomatitis
06/2014
1Pain (Aches)
06/2014
1Solitary Kidney
04/2014
1Residual Neoplasm
09/2013
1Hyperbilirubinemia
04/2013

Drug/Important Bio-Agent (IBA)

28Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 07/2010
24Bortezomib (Velcade)FDA Link
01/2022 - 04/2006
19Lenalidomide (CC 5013)FDA Link
06/2022 - 08/2010
13daratumumabIBA
01/2022 - 01/2017
7venetoclaxIBA
11/2021 - 11/2017
7Proteasome InhibitorsIBA
01/2019 - 03/2007
6Monoclonal AntibodiesIBA
12/2020 - 01/2006
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2018 - 06/2009
5Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2011
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 04/2012
5plerixaforFDA Link
01/2018 - 06/2009
5Rituximab (Mabthera)FDA Link
11/2015 - 04/2012
4carfilzomibIBA
10/2021 - 06/2012
3elotuzumabIBA
06/2022 - 06/2012
3Immunoglobulins (Immunoglobulin)IBA
02/2022 - 08/2013
3filanesibIBA
01/2022 - 11/2016
3Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 04/2014
3Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019 - 04/2006
3Vincristine (Oncovin)FDA LinkGeneric
11/2015 - 04/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 04/2012
2KinesinsIBA
01/2022 - 11/2016
2VorinostatFDA Link
12/2020 - 01/2016
2Histone Deacetylase InhibitorsIBA
12/2020 - 08/2013
2Biological ProductsIBA
12/2019 - 01/2013
2ixazomibIBA
01/2019 - 12/2014
2PanobinostatIBA
01/2019 - 10/2014
2Prednisone (Sone)FDA LinkGeneric
11/2015 - 07/2012
2Pharmaceutical PreparationsIBA
12/2014 - 10/2014
1VaccinesIBA
10/2022
1Pregabalin (Lyrica)FDA Link
01/2022
1Gabapentin (Neurontin)FDA LinkGeneric
01/2022
1Immunoglobulin M (IgM)IBA
11/2021
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
01/2021
1vendexIBA
01/2021
1isatuximabIBA
12/2020
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019
1PVX-410 vaccineIBA
12/2018
1pomalidomideIBA
01/2017
1Immunoglobulin G (IgG)IBA
03/2016
1CreatinineIBA
03/2016
1marizomibIBA
01/2016
114- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
01/2016
1ParaproteinsIBA
03/2015
1Immunomodulating AgentsIBA
09/2014
1Fibroblast Growth Factor 7FDA Link
06/2014
1Busulfan (Busulfex)FDA Link
06/2014
1Etoposide (VP 16)FDA LinkGeneric
06/2014
1milatuzumabIBA
11/2013
1Antineoplastic Agents (Antineoplastics)IBA
08/2013

Therapy/Procedure

26Therapeutics
02/2022 - 04/2006
7Stem Cell Transplantation
06/2022 - 06/2009
4Transplantation
06/2022 - 01/2013
3Hematopoietic Stem Cell Transplantation
01/2018 - 04/2014
3Hematopoietic Stem Cell Mobilization
09/2013 - 08/2011
2Immunotherapy
01/2018 - 11/2013
2Blood Component Removal (Apheresis)
09/2013 - 08/2011
1Radiotherapy
01/2018
1Immunomodulation
01/2017
1Drug Tapering
11/2015
1Drug Therapy (Chemotherapy)
02/2015
1Length of Stay
06/2014
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
06/2014
1Intravenous Administration
09/2013